LMR Partners’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.48M | Buy |
+550,000
| New | +$5.48M | 0.04% | 234 |
|
|
2025
Q1 | – | Sell |
-22,972
| Closed | -$176K | – | 1013 |
|
|
2024
Q4 | $176K | Hold |
22,972
| – | – | ﹤0.01% | 569 |
|
|
2024
Q3 | $235K | Hold |
22,972
| – | – | ﹤0.01% | 492 |
|
|
2024
Q2 | $341K | Hold |
22,972
| – | – | ﹤0.01% | 427 |
|
|
2024
Q1 | $313K | Buy |
+22,972
| New | +$313K | ﹤0.01% | 407 |
|
|
2023
Q4 | – | Sell |
-17,972
| Closed | -$197K | – | 762 |
|
|
2023
Q3 | $197K | Hold |
17,972
| – | – | ﹤0.01% | 445 |
|
|
2023
Q2 | $238K | Sell |
17,972
-94,947
| -84% | -$1.26M | ﹤0.01% | 454 |
|
|
2023
Q1 | $1.54M | Buy |
112,919
+82,700
| +274% | +$1.13M | 0.02% | 490 |
|
|
2022
Q4 | $590K | Hold |
30,219
| – | – | 0.01% | 810 |
|
|
2022
Q3 | $576K | Buy |
30,219
+10,000
| +49% | +$191K | 0.01% | 831 |
|
|
2022
Q2 | $417K | Buy |
+20,219
| New | +$417K | 0.01% | 955 |
|